Francesco Malandrini

Government, Health and Not for Profit

Fellow

Health Policy

francesco.malandrini@sdabocconi.it

Download v-card Download pdf

Pubblicazioni recenti

Valsecchi A. A., Giovanardi F., MALANDRINI F., MEREGAGLIA M., Servetto A., Bennati C., Pinto C., Di Maio M., CIANI O. Breast-cancer specific comprehensive archive of Patient-Reported Outcome Measures (PROMs) for clinical research and clinical practice in oncology: Results from the PRO4All project The Breast, 2024, vol.78, pp.103817

MALANDRINI F., MEREGAGLIA M., Di Maio M., Pinto C., De Lorenzo F., CIANI O. The development of an archive of patient-reported outcome measures (PROMs) in oncology: The Italian PRO4All project European Journal of Cancer, 2024, vol.207, pp.114161

ARMENI P., CALLEA G., COSTA F., MALANDRINI F., OTTO M., SEGANTIN G., SIRENA P., TARRICONE R. Il payback come misura di contenimento della spesa per farmaci e dispositivi medici in Rapporto OASI 2023 CERGAS (a cura di), Egea, chap. 17, pp.651-698, 2023

ARMENI P., COSTA F., JOMMI C., MALANDRINI F., OTTO M., TARANTOLA A. L’evoluzione del finanziamento dei farmaci in Italia in Rapporto OASI 2023 CERGAS (a cura di), Egea, chap. 8, pp.317-354, 2023

MEREGAGLIA M., MALANDRINI F., Angelini S., CIANI O. The Assessment of Patient-Reported Outcomes for the Authorisation of Medicines in Europe: A Review of European Public Assessment Reports from 2017 to 2022 Applied Health Economics and Health Policy, 2023, no. 21, pp.925-935

TARANTOLA A., OTTO M., ARMENI P., COSTA F., MALANDRINI F., JOMMI C. Early access programs for medicines: comparative analysis among France, Italy, Spain, and UK and focus on the Italian case Journal of Pharmaceutical Policy and Practice, 2023, vol.16, no. 1, pp.67

Download